ROCK SIMCHA enters PURPLE BIOTECH LTD. with 3.21M shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 4/17/2026ACC: 0001213900-26-044999
3.21M
Baseline shares
100% direct
3.21M
Direct ownership
1 position
2.95M
Derivative underlying
2 instruments
1
Security positions
All direct
Non-Derivative Holdings1
Ordinary Shares
DirectShares owned3.21M
Total
3.21M direct3.21M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Ordinary Shares | 3.21M | Direct |
| Total | 3.21M | 3.21M direct |
Derivative Holdings2
Stock Option (Right to Buy)
DirectUnderlying security
Ordinary Shares
Underlying shares
300K
Shares owned
N/A
Exercise price
Expiration
—
Exercise window
—
Stock Option (Right to Buy)
DirectUnderlying security
Ordinary Shares
Underlying shares
2.65M
Shares owned
N/A
Exercise price
Expiration
—
Exercise window
—
Total
Underlying
2.95M
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Ordinary Shares | — | — | 300K | N/A | |
| Stock Option (Right to Buy) Direct | Ordinary Shares | — | — | 2.65M | N/A | |
| Total | 2.95M | 0.00 | ||||